{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T13:10:08Z","timestamp":1756732208960,"version":"3.44.0"},"reference-count":29,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":243,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S2732494X25101137_as1\">\n\t    <jats:title>Background:<\/jats:title>\n\t    <jats:p><jats:italic>Clostridioides difficile<\/jats:italic> infections (CDI) increased at a large, regional hospital in New South Wales, Australia, in 2021, coinciding with an increase at hospitals Australia wide. We aimed to investigate the association between antibiotic prescribing practices and hospital-acquired CDI at the hospital to inform antimicrobial stewardship (AMS) programs.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2732494X25101137_as2\">\n\t    <jats:title>Methods:<\/jats:title>\n\t    <jats:p>We conducted a retrospective case\u2013control study for the period July 1, 2018, and June 30, 2022. Seventy hospital-acquired CDI cases were selected for the study. Cases were matched on a 1:2 basis with randomly selected controls based on date of hospitalization and age group. We conducted a multivariable analysis to explore possible risk factors for infection. We compared cases and controls who were administered antibiotics to determine if rates of inappropriate antibiotic prescriptions differed between cases and controls.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2732494X25101137_as3\">\n\t    <jats:title>Results:<\/jats:title>\n\t    <jats:p>The multivariable model found that use of cephalosporins (third, fourth, or fifth generation) (adjusted odds ratio (aOR) 3.82, 95% confidence interval (CI) 1.35\u201310.84), use of penicillins (broad or extended broad spectrum) (aOR 5.79, 95% CI 2.15\u201315.58), and increased complexity of comorbidities (aOR 1.22, 95% CI 1.02\u20131.45) were independently associated with CDI. In patients who had antibiotics administered during their admission, inappropriate antibiotic prescribing (OR 5.68, 95% CI 1.95\u201316.48) and non-compliance with antibiotic prescribing guidelines (OR 5.01, 95% CI 1.07\u201314.76) were associated with CDI.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2732494X25101137_as4\">\n\t    <jats:title>Conclusions:<\/jats:title>\n\t    <jats:p>Our study showed that antibiotic prescribing practices were associated with hospital-acquired CDI at the hospital during the study period. The results reinforce the importance of compliance with antibiotic guidelines and provide further evidence for AMS programs to reduce CDI.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/ash.2025.10113","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:50:03Z","timestamp":1756731003000},"source":"Crossref","is-referenced-by-count":0,"title":["<i>Clostridioides difficile<\/i> infection and antibiotic prescribing at a regional hospital in Australia: a case\u2013control study"],"prefix":"10.1017","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1096-619X","authenticated-orcid":false,"given":"Sarah Elizabeth","family":"Alland","sequence":"first","affiliation":[{"name":"Australian National University"},{"name":"Hunter New England Local Health District"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8219-6912","authenticated-orcid":false,"given":"Bianca","family":"Mills","sequence":"additional","affiliation":[{"name":"Hunter New England Local Health District"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8168-8244","authenticated-orcid":false,"given":"Michelle","family":"Bolte","sequence":"additional","affiliation":[{"name":"Hunter New England Local Health District"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-1485","authenticated-orcid":false,"given":"Colleen","family":"Ma","sequence":"additional","affiliation":[{"name":"Hunter New England Local Health District"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-7774","authenticated-orcid":false,"given":"Sally","family":"Munnoch","sequence":"additional","affiliation":[{"name":"Hunter New England Local Health District"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-2139","authenticated-orcid":false,"given":"Matthew","family":"Kelly","sequence":"additional","affiliation":[{"name":"Australian National University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"S2732494X25101137_ref21","unstructured":"21. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2024. 2023. Norwegian Institute of Public Health. https:\/\/atcddd.fhi.no\/atc_ddd_index_and_guidelines\/guidelines\/. Accessed January 22, 2025."},{"key":"S2732494X25101137_ref24","unstructured":"24. Australian Commission on Safety and Quality in Health Care. Monitoring the national burden of clostridioides difficile infection in Australian public hospitals: 2016 to 2018. 2021. Australian Commission on Safety and Quality in Health Care. https:\/\/www.safetyandquality.gov.au\/publications-and-resources\/resource-library\/monitoring-national-burden-clostridioides-difficile-infection-australian-public-hospitals-2016-2018. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref26","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_44_19"},{"key":"S2732494X25101137_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt477"},{"key":"S2732494X25101137_ref22","unstructured":"22. Antibiotics. Therapeutic guidelines. 2019. https:\/\/www.tg.org.au. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref4","unstructured":"4. Centers for Disease Control and Prevention. C. diff: facts for clinicians. 2024. Centers for disease control and prevention. https:\/\/www.cdc.gov\/c-diff\/hcp\/clinical-overview\/index.html. Updated March 5, 2024. Accessed June 17, 2024"},{"key":"S2732494X25101137_ref11","unstructured":"11. Royal Melbourne Hospital and the National Centre for Antimicrobial Stewardship. National Antimicrobial Prescribing Survey: technical supplement 2022. 2024. Royal Melbourne Hospital and the National Centre for Antimicrobial Stewardship. https:\/\/www.amr.gov.au\/sites\/default\/files\/2024-05\/national-antimicrobial-prescribing-survey-2022-technical-supplement.pdf. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref28","unstructured":"28. Australian Government. Australia\u2019s National Antimicrobial Resistance Strategy - 2020 and Beyond. 2019. Australian Government. https:\/\/www.amr.gov.au\/sites\/default\/files\/2022-11\/australia-s-national-antimicrobial-resistance-strategy-2020-and-beyond_0.pdf. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2004.03.012"},{"key":"S2732494X25101137_ref18","unstructured":"18. Sergeant, E. Epitools epidemiological calculators. 2018. Ausvet. http:\/\/epitools.ausvet.com.au. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref14","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.4816"},{"key":"S2732494X25101137_ref6","unstructured":"6. National Institute for Health and Care Excellence. Clostridium difficile infection: risk with broad-spectrum antibiotics. 2015. National Institute for Health and Care Excellence. https:\/\/www.nice.org.uk\/advice\/esmpb1\/chapter\/Key-points-from-the-evidence. Accessed September 23, 2024"},{"key":"S2732494X25101137_ref10","unstructured":"10. SA Health. Data from: national antimicrobial utilisation surveillance program Usage rates - study hospital. In National Antimicrobial Utilisation Surveillance Program 2024. Accessed May 20, 2024. (Unpublished)."},{"key":"S2732494X25101137_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"S2732494X25101137_ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00646"},{"key":"S2732494X25101137_ref9","unstructured":"9. Australian Commission on Safety and Quality in Health Care. Implementation Guide for Surveillance of Clostridium difficile infection 2020. 2023. https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2021-03\/surveillance_guide_cdi_july_2020_indesign_final_version.pdf. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref5","unstructured":"5. Australian Commission on Safety and Quality in Health Care. Clostridioides difficile infection data snapshot report: 2020 and 2021. 2023. Australian Commission on Safety and Quality in Health Care. https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2023-07\/cdi_snapshot_report_2020_and_2021_pdf_version.pdf. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1403772"},{"key":"S2732494X25101137_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.840846"},{"key":"S2732494X25101137_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00833-x"},{"key":"S2732494X25101137_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2135"},{"key":"S2732494X25101137_ref2","article-title":"Clostridium difficile infection (Primer)","volume":"2","author":"Smits","year":"2016","journal-title":"Nat Rev: Dis Primers"},{"key":"S2732494X25101137_ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105454"},{"key":"S2732494X25101137_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.08.020"},{"key":"S2732494X25101137_ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3841-6"},{"key":"S2732494X25101137_ref25","unstructured":"25. Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in Australian health care. 2022. Australian Commission on Safety and Quality in Health Care. https:\/\/www.safetyandquality.gov.au\/publications-and-resources\/resource-library\/antimicrobial-stewardship-australian-health-care. Accessed September 23, 2024."},{"key":"S2732494X25101137_ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4603-1"},{"key":"S2732494X25101137_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009316"},{"key":"S2732494X25101137_ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X25101137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:50:07Z","timestamp":1756731007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X25101137\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S2732494X25101137"],"URL":"https:\/\/doi.org\/10.1017\/ash.2025.10113","relation":{},"ISSN":["2732-494X"],"issn-type":[{"value":"2732-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e198"}}